A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins
On Tuesday, Merck reported better-than-expected first-quarter profits, driven by a huge jump in sales of its cancer drug, Keytruda.
The Beating Cancer Is in Our Blood brand positioning was developed with Oberland.
At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation
For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.